← All peptides
Cognitive & Nootropic
Research Chemical

N-Acetyl Semax Amidate / N-Acetyl Selank Amidate Blend

Also known as: N-Acetyl Semax Amidate / N-Acetyl Selank Amidate Blend

A research blend of two stabilized Russian-developed neuropeptides: N-Acetyl Semax (a nootropic ACTH fragment) and N-Acetyl Selank (an anxiolytic tuftsin analog). The combination is studied for cognition, focus, and stress modulation.

Last updated

Mechanism of Action

Semax is a synthetic analog of ACTH(4-10) that increases brain-derived neurotrophic factor (BDNF) and its receptor TrkB, modulates the dopaminergic and serotonergic systems, and inhibits enkephalin-degrading enzymes to extend endogenous neuropeptide activity. Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin that modulates GABAergic and serotonergic tone, alters expression of interleukins and BDNF, and produces anxiolytic effects without sedation. The N-acetyl and amidate modifications protect both peptides from peptidase degradation, improving stability for intranasal delivery, and the blend pairs cognitive enhancement with stress reduction.

Half-life
Short for both parent peptides (minutes); the N-acetyl and amidate modifications extend duration of action to several hours.
Administration Routes
intranasal, subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Studied for enhanced focus, memory, and learning
  • May reduce anxiety without sedation
  • Explored for increased BDNF and neurotrophic support
  • Investigated for improved stress resilience and mood
  • Combines nootropic and anxiolytic peptide actions
  • Stabilized forms intended for intranasal absorption

Potential Side Effects

  • Nasal irritation or congestion with intranasal use
  • Mild headache
  • Fatigue or overstimulation in some users
  • Unknown effects from combining peptides
  • Limited long-term human safety data

Common Dosing

For research use only and not medical advice; literature describes intranasal Semax and Selank in the ~250-900 mcg per dose range one to three times daily for the individual peptides. The blend has no standardized protocol and varies by vendor.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy and breastfeeding
  • Known hypersensitivity to either peptide
  • Caution with other serotonergic or CNS-active agents
  • Functional Connectomic Approach to Studying Selank and Semax Effects

    2020

    View
  • Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

    2006

    View
  • [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]

    2014

    View
  • Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats

    2017

    View

N-Acetyl Semax is studied mainly as a nootropic that boosts focus and BDNF, while N-Acetyl Selank is studied as an anxiolytic that modulates GABA and serotonin without sedation.

They are chemical modifications to the peptide termini that protect against enzymatic breakdown, increasing stability and duration compared with the unmodified versions.

Semax and Selank are used clinically in Russia, but neither is FDA-approved; the blend is sold for research purposes only.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.